Lifevantage Corporation
Research Lifevantage Corporation (LFVN) on Bullrun: valuation model: 18.4% undervalued, market cap USD 75.11M, P/E 15.1, dividend yield 3.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLFVN
- ExchangeNASDAQ
- CountryUnited States
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyUSD
- Valuation signal18.4% undervalued
- Market capUSD 75.11M
- P/E15.1
- Dividend yield3.2%
- Financial periodFY2026
- RevenueUSD 182.59M
- Revenue growth-20.1%
- Net incomeUSD 5.07M
- Free cash flowUSD 6.67M
- Gross margin77.6%
Valuation Snapshot
Bullrun's latest valuation model marks Lifevantage Corporation as 18.4% undervalued; latest market cap is USD 75.11M; P/E is 15.1; dividend yield is 3.2%.
Peer valuation comparison
Latest P/E is 15.09x versus a Consumer Defensive sector median of 17.24x (12.5% below).
Latest dividend yield is 3.18% versus a Consumer Defensive sector median of 3.01% (5.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 182.59M | USD 5.07M | USD 6.67M | 77.6% | 0.4 | USD 14.92M | USD 9.87M | USD 33.59M |
| FY2025 | USD 228.53M | USD 9.81M | USD 10.51M | 80.4% | 0.75 | USD 20.20M | USD 11.68M | USD 34.64M |
| FY2024 | USD 200.16M | USD 2.94M | USD 9.95M | 79.3% | 0.23 | USD 16.89M | USD 13.61M | USD 25.99M |
| FY2023 | USD 213.40M | USD 2.54M | USD 3.76M | 79.7% | 0.2 | USD 21.61M | USD 13.09M | USD 34.65M |
| FY2022 | USD 206.36M | USD 3.12M | USD 6.43M | 81.5% | 0.24 | USD 20.19M | USD 15.76M | USD 31.52M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 75.11M | 15.1 | 3.2% | 0.19 |
| 2025 | 2025-12-31 | USD 78.77M | 10.3 | 3.1% | 0.19 |
| 2024 | 2024-12-31 | USD 220.00M | 30.8 | 0.9% | 0.16 |
| 2023 | 2023-12-29 | USD 76.28M | 30.0 | 9.2% | 0.55 |
| 2022 | 2022-12-30 | USD 46.72M | 124.0 | 2.4% | 0.09 |
| 2021 | 2021-12-31 | USD 81.17M | 8.7 | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.19 USD, yield 3.2%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.15 USD |
| FY2025 | 0.17 USD |
| FY2024 | 0.55 USD |
| FY2023 | 0.13 USD |
| FY2022 | 0.03 USD |
About Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health;
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
Is Lifevantage Corporation overvalued or undervalued?
Bullrun's valuation model currently marks Lifevantage Corporation as 18.4% undervalued.
What is Lifevantage Corporation's market cap?
Lifevantage Corporation's market capitalization is USD 75.11M.
What is Lifevantage Corporation's P/E ratio?
Lifevantage Corporation's price-to-earnings (P/E) ratio is 15.1.
Does Lifevantage Corporation pay a dividend?
Lifevantage Corporation has a dividend yield of 3.2%.
What does Lifevantage Corporation do?
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally.